Quanterix (QTRX) Net Cash Flow Growth (1y) (2018 - 2026)
Quanterix (QTRX) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 76.43% |
| 10 | Quanterix | 178.99 Mn | 79.72 Mn | 15.57 Mn | -66.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.33% |
| Dec 31, 2025 | -130.32% |
| Sep 30, 2025 | -421.01% |
| Jun 30, 2025 | 3,189.86% |
| Mar 31, 2025 | 114.73% |
| Dec 31, 2024 | 202.76% |
| Sep 30, 2024 | 85.93% |
| Jun 30, 2024 | 369.81% |
| Mar 31, 2024 | -1,268.48% |
| Dec 31, 2023 | -450.53% |
| Sep 30, 2023 | -609.25% |
| Jun 30, 2023 | 102.83% |
| Mar 31, 2023 | 56.42% |
| Dec 31, 2022 | 62.08% |
| Sep 30, 2022 | 8.95% |
| Jun 30, 2022 | -7.02% |
| Mar 31, 2022 | -108.25% |
| Dec 31, 2021 | -258.85% |
| Sep 30, 2021 | -123.50% |
| Jun 30, 2021 | -53.99% |